J. Mayrhofer

发表

Monoclonal Antibodies Targeting the HR2 Domain and the Region Immediately Upstream of the HR2 of the S Protein Neutralize In Vitro Infection of Severe Acute Respiratory Syndrome Coronavirus

W. Hong, S. Lim, F. Falkner, 2006, Journal of Virology.

Overexpression of hepatitis B virus surface antigens including the preS1 region in a serum-free Chinese hamster ovary cell line.

G. Webersinke, J. Leitner, F. Falkner, 2003, Protein expression and purification.

Generation of Transduction-Competent Retroviral Vectors by Infection with a Single Hybrid Vaccinia Virus

F. Falkner, J. Mayrhofer, T. Hämmerle, 2003, Journal of Virology.

Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection

W. Hong, F. Falkner, P. N. Barrett, 2009, Journal of Virology.

The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.

F. Falkner, J. Mayrhofer, S. Coulibaly, 2005, Virology.

Development of an In Vitro Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release

J. Lengler, F. Falkner, J. Mayrhofer, 2020, Molecular therapy. Methods & clinical development.

Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection.

H. Ehrlich, F. Falkner, P. N. Barrett, 2011, Vaccine.

Dominant host range selection of vaccinia recombinants by rescue of an essential gene.

F. Falkner, F. Dorner, J. Mayrhofer, 1998, Virology.

Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.

F. Falkner, F. Dorner, J. Mayrhofer, 1999, Virology.

Nonreplicating Vaccinia Virus Vectors Expressing the H5 Inﬂuenza Virus Hemagglutinin Produced in Modiﬁed Vero Cells Induce Robust Protection (cid:1)

F. Falkner, J. Mayrhofer, B. Crowe, 2009 .

An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system

F. Falkner, J. Mayrhofer, J. Schwaiger, 2010, Vaccine.

Dominant negative selection of vaccinia virus using a thymidine kinase/thymidylate kinase fusion gene and the prodrug azidothymidine.

F. Falkner, J. Mayrhofer, G. Holzer, 2005, Virology.

Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection

W. Hong, F. Falkner, J. Mayrhofer, 2009, Journal of Virology.